INVITATION: September 27 and 28 - Opioid and Nicotine Use, Dependence and Recovery: Influence of Sex and Gender Scientific Conference

Opioid and Nicotine Use, Dependence, and Recovery:Influences of Sex and Gender Scientific Conference

Join the FDA Office of Women’s Health, in collaboration with the  Center for Drug Evaluation and Research and Center for Tobacco  Products, for a conference on Opioid and Nicotine Use,  Dependence, and Recovery: Influences of Sex and Gender.  This public meeting will be held on September 27 and 28, 8:30 AM  – 4:00 PM, FDA White Oak Campus,  10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great  Room (Rm. 1503-A), Silver Spring, MD 20993. This two-day scientific conference will begin with keynote speeches  by FDA Commissioner Scott Gottlieb and the U.S. Surgeon General,  VADM Jerome M. Adams, M.D., M.P.H. Presentations will follow from  researchers, clinicians, and policy experts discussing sex and gender  influences on substance misuse, abuse, and cessation. To register to attend this special event or view the webcast,  go to https://go.usa.gov/xUk8P. Space is limited for in-person  attendance, so register early. If you have questions about the conference, please email  to OWH_OandNConf@fda.hhs.gov.